Cover Image

COMBI-EU: real-world evidence on adverse event management and time on therapy with adjuvant dabrafenib plus trametinib in patients with BRAF V600-mutant melanoma

Simple SummaryThe prospective, non-interventional COMBI-EU study investigated the impact of adverse event management, and app-based health-tracking on...

Saved in:
Bibliographic Details
Main Authors: Weichenthal, Michael (Author) , Debus, Dirk (Author) , Zimmer, Lisa (Author) , Wasielewski, Imke von (Author) , Meier, Friedegund (Author) , Tüting, Thomas (Author) , Wohlrab, Johannes (Author) , Utikal, Jochen (Author)
Format: Article (Journal)
Language:English
Published: 18 February 2026
In: Cancers
Year: 2026, Volume: 18, Issue: 4, Pages: 1-17
ISSN:2072-6694
DOI:10.3390/cancers18040667
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/cancers18040667
Verlag, kostenfrei, Volltext: https://www.mdpi.com/2072-6694/18/4/667
Get full text
Author Notes:by Michael Weichenthal, Dirk Debus, Lisa Zimmer, Imke von Wasielewski, Friedegund Meier, Thomas Tüting, Johannes Wohlrab, Jochen Utikal [und weitere]
Description
Summary:Simple SummaryThe prospective, non-interventional COMBI-EU study investigated the impact of adverse event management, and app-based health-tracking on...
Item Description:Gesehen am 19.03.2026
Physical Description:Online Resource
ISSN:2072-6694
DOI:10.3390/cancers18040667

Similar Items